Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - Estonia
Summary - Antineoplastic And Endocrinological Agents (L01-L02)
Deadline - Feb 17, 2025
GT reference number - 101821681
Product classification - Pharmaceutical products
Address - Estonia
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 101821681
Document Type - Tender Notices
Description - Description: Purchase of medicines as described in RHAD Annex I Technical Specification-Tender Form.local title:: Kasvajavastased ja endokrinoloogilised ained (L01-L02)Contract Type: : Supplylocal description: : Ravimite ostmine vastavalt RHAD lisas I Tehniline kirjeldus-pakkumuse vorm kirjeldatule.Net Budget Euro: : 12398000.0Net Budget LC: : 12398000.0 dispatch_date: 2025-01-16 00:00:00 est_amount: 12398000.0 lot_details: 1: Cyclophosphamide, 2: Ifosfamide, 3: Temosolomiid, 4: Methotrexate, 5: Pemetrekseed, 6: Fluorouratsiil, 7: Gemcitabine, 8: Capecitabine, 9: Vinorelbine, 10: Etoposide, concentrate for solution for infusion, 100mg-200mg per vial, 11: Etoposide, soft capsule, 100mg, 12: P
Gt Ref Id - 101821681
Deadline - Feb 17, 2025
Similar Tenders :
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database